DBV Technologies | DBVT - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amarin USD 12.54M 28.57M 2025-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
DBV Technologies USD -45.9M 12.42M 2026-03
Galectin Therapeutics USD -7.42M 819K 2021-12
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Insmed USD -148.3M 165.88M 2026-03
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
PTC Therapeutics USD 61.98M 132.97M 2026-03
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
United Therapeutics USD 355M 11.1M 2026-06